NRG Oncology Foundation, Inc: Member Institution Purchased Service Agreement (PSA)

Project: Research project

Project Details


WHEREAS, NRG Oncology seeks to improve the lives of cancer patients by conducting practice-changing multi-institutional clinical and translational research with emphases on gender-specific malignancies including gynecologic, breast and prostate cancers and on localized or locally advanced cancers of all types; WHEREAS, NRG Oncology anticipates to receive award(s) from the National Institutes of Health (“NIH”) and the National Cancer Institute (“NCI”) to conduct oncology clinical trials; WHEREAS, the Parties desire for Institution to participate in the conduct of the clinical trials;
Effective start/end date3/1/147/31/19


  • NRG Oncology Foundation, Inc. (Agmt Signed 9/5/14 // Agmt Signed 9/5/14)
  • National Cancer Institute (Agmt Signed 9/5/14 // Agmt Signed 9/5/14)


Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.